Game over: Bristol Myers, Nektar end $3.6B immuno-oncology program after 2 more late-stage flops National Nurses United survey shows spikes in workplace violence, staffing issues remain Bristol Myers settles HIV antitrust suit, but J&J, Gilead still await their day in court Siemens Healthineers kicks off expansion plan by doubling size of Corindus HQ U2 disbands: In a crushing step back, TG retracts FDA request for combo therapy due to death risk Lawmakers blast McKinsey for 'serious conflict of interest' in opioid consulting NEBGH launches guide for employers to address diabetes, obesity through an equity lens FDA greenlights first breathalyzer test for COVID-19 10x Genomics debuts sample prep kits to expand access to single-cell research DOJ probes Bausch over marketing, sales tactics for 4 meds: report AstraZeneca's Alexion, Arvinas nab space at future 10-story biotech tower in New Haven How to leverage artificial intelligence to combat inequities: McKinsey Fujifilm lands $450M DOD contract to provide endoscopy tools, training to government hospitals Featured Story | By Nick Paul Taylor Bristol Myers Squibb and Nektar have read the last rites to their huge, failed cancer collaboration. With two more late-stage trials failing, the partners have ended clinical development of a combination they once saw as the future of immuno-oncology. read more |
| |
|---|
|
| | Full-time Consulting Careers IPM is an industry leader in Life Sciences consulting and has managed projects for more than 150 biotech, pharma, and medtech companies. Learn how you can lead a variety of impactful projects with us. Explore here! |
Top Stories By Robert King A new survey of registered nurses shows that incidents of workplace violence have spiked as well as increases in burnout at hospitals across the country. read more By Fraiser Kansteiner The first of the three pharma juggernauts accused of monopolizing the market for HIV drugs is putting its legal woes to bed, courtesy of a settlement agreement under review at a federal court in California. read more By Andrea Park Less than three years after acquiring Corindus, Siemens Healthineers is moving the surgical robot maker from its longtime home in one Boston suburb to another. read more By Max Bayer TG Therapeutics is heading back to the drawing board after new data showed its cancer drug had an elevated risk of death, plucking Ukoniq off the market for the two indications it won accelerated approval for, in addition to withdrawing an approval request for a combo med. read more By Kevin Dunleavy Global consulting firm McKinsey is under scrutiny from Congress after revelations that at least 22 employees who were consulting Purdue Pharma and other opioid producers were also doing work for government agencies tasked with regulating opioid use. The double-dipping represented a “serious conflict of interest,” according to a congressional report. read more By Paige Minemyer Employers have long been focused on addressing obesity and diabetes in their workforces. However, COVID-19 is pushing them to think about these health challenges in new ways. read more By Conor Hale The portable breathalyzer developed by InspectIR Systems aims to deliver a result within three minutes by looking for the exhaled chemical compounds that can come with an infection. read more By Conor Hale They include methods to preserve fragile human tissues as well as a way to more easily access frozen samples. read more By Zoey Becker Bausch Health is back in hot water, this time because the DOJ is reportedly investigating its marketing of four drugs. read more By Gabrielle Masson Some biotechs are building as others crumble, with several industry players–including AstraZeneca's Alexion and Arvinas involved in plans for a new 10-floor tower built for burgeoning biotechs. read more By Anastassia Gliadkovskaya Two of the firm’s partners spoke at a Northwell Health event on AI in healthcare this week. In their panel, they provided many examples of how to harness AI to solve inequities while also cautioning against tech-driven bias. read more By Andrea Park The Defense Department contract was awarded in February, when Fujifilm beat out more than 50 other applicants to secure the five-year deal. read more |
